Literature DB >> 13701598

Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year.

A FREEDMAN, V L STEINBERG.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID/therapy; CHLOROQUINE/therapy

Mesh：

Substances：

Year:  1960        PMID： 13701598      PMCID： PMC1007150          DOI： 10.1136/ard.19.3.243

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

1.  [Use of synthetic antimalarials in primary chronic polyarthritis].

Authors:  R K KUIPERS
Journal:  Z Rheumaforsch       Date:  1959-06

2.  Medical and social aspects of the treatment of rheumatoid arthritis; with special reference to factors affecting prognosis.

Authors:  J J DUTHIE; M THOMPSON; M M WEIR; W B FLETCHER
Journal:  Ann Rheum Dis       Date:  1955-06       Impact factor: 19.103

3.  [Chloroquine treatment of 20 patients with active rheumatoid arthritis].

Authors:  F ERLENDSSON
Journal:  Ugeskr Laeger       Date:  1958-06-19

4.  Treatment of rheumatoid arthritis with chloroquine.

Authors:  H FULD; L HORWICH
Journal:  Br Med J       Date:  1958-11-15

5.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

6.  Proposed diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Ann Rheum Dis       Date:  1957-03       Impact factor: 19.103

7.  A controlled study of chloroquine as an antirheumatic agent.

Authors:  A S COHEN; E CALKINS
Journal:  Arthritis Rheum       Date:  1958-08

8.  Chloroquine and rheumatoid arthritis; a short-term controlled trial.

Authors:  A FREEDMAN
Journal:  Ann Rheum Dis       Date:  1956-09       Impact factor: 19.103

9.  [Serological research in chronic inflammatory rheumatism; study of antistreptolysin O].

Authors:  J FORESTIER; A CERTONCINY
Journal:  Rev Rhum Mal Osteoartic       Date:  1954-05

10.  Mepacrine and rheumatoid arthritis.

Authors:  A FREEDMAN; F BACH
Journal:  Lancet       Date:  1952-08-16       Impact factor: 79.321
View more
  27 in total

1.  In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?

Authors:  R J Rooney; W W Buchanan
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.

Authors:  I H Nuver-Zwart; P L van Riel; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

3.  Action of chloroquine phosphate in rheumatoid arthritis. 1. Immunosuppressive effect.

Authors:  G S Panayi; W A Neill; J J Duthie; J N McCormick
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

4.  Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study.

Authors:  P D Fowler; M F Shadforth; P R Crook; A Lawton
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

5.  Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis.

Authors:  S P Percival; I Meanock
Journal:  Br Med J       Date:  1968-09-07

6.  Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial.

Authors:  A A Kruize; R J Hené; C G Kallenberg; O P van Bijsterveld; A van der Heide; L Kater; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

7.  Chloroquine in long-term treatment of rheumatoid arthritis.

Authors:  A Bjelle; A Björnham; A Larsen; T Mjörndal
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

8.  Chloroquine retinopathy: is there a safe daily dose?

Authors:  J S Marks
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

9.  Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness.

Authors:  R B Landewé; A M Miltenburg; M J Verdonk; C L Verweij; F C Breedveld; M R Daha; B A Dijkmans
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Ileum-targeted steroid therapy in rheumatoid arthritis: double-blind, placebo-controlled trial of controlled-release budesonide.

Authors:  P Sheldon
Journal:  Rheumatol Int       Date:  2003-03-06       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.